Meet the Aberdeen pupil who is siting S4 exams in primary school
An 11-year-old Aberdeen schoolboy who is in primary seven sat his National 4 exams – usually taken in fourth year – at the age of 10.
Emon Rizvi, who attends the city's Albyn School, showed potential from a young age.
So much so, that he never started primary one and went straight into primary two.
'P1 was too easy for him, so we just wanted him to go into P2,' his dad Imran – a 45-year-old businessman – told The Press and Journal.
The youngster was so adamant that he was not starting primary school in the usual age group and said at the time: 'I'm not wasting my time in P1 because it is so easy for me.'
His time at Albyn has been successful and according to his teachers, he has shown 'exceptional aptitude' for learning since he started.
The 11-year-old has now made history and has officially been accepted into Mensa International, the world-renowned high IQ society.
The youngest an individual can do a supervised IQ test for the organisation is at the age of 10 and a half, with people who score at the 98th percentile or higher getting accepted.
Emon completed – and passed – one of Mensa's mock test at the age of nine.
'He was so excited when he turned 10 years and six months,' Imran told The P&J.
When he was of the age allowed, 10-year-old Emon – who enjoys playing video games, Lego and tennis – took his test to see if he would be eligible to qualify for Mensa.
Taking the Stanford-Binet test – in which to qualify you need to be in the top 2% (scoring 132 or more) – the schoolboy surpassed this and scored 149.
Speaking to the P&J, Emon said: 'I'm very proud of myself and both my parents and my brother are very proud.
'I feel almost astonished that I managed, because I thought It'd be really, really hard. I am also relieved that I managed.'
In achieving this, he has become the first ever pupil from Albyn's lower school to join the elite club.
Head of Albyn's lower school, Mr Davies said: 'He has this intense focus and incredible memory.
'Emon's talents are far beyond his years.'
Having sat his National 4 exams last year, there are plans for him to do 'two or three' Highers in second year if he does well at 'mock' National 5 exams that he is taking this year.
And what are Emon's plans for the future?
'It's difficult because he has no pressure, his dad said, adding: 'He will decide what he wants to do.
'However, it will probably be in artificial intelligence or something.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
2 days ago
- The Guardian
Social climbing isn't about who you know after all, study finds
When it comes to social climbing, it's not who you know, or how many people you know, it's about knowing who knows whom, research suggests. Experts studying social connections made by first year university students say those who ended up with the most influence were not necessarily the most popular, but those who had a good idea, early on, about who belonged to which clique or community. 'Having friends helps, but social influence isn't just about who you know – it's also about what you know about the rest of your social network,' said Isabella Aslarus, first author of the study from Stanford University. Writing in the journal Science Advances, researchers in the US report how they asked 187 students to complete surveys about who they were friends with at six different points during their first year at university. The team used the results to map the connections between individuals, and how these changed with time. At two points, once shortly after the start of the academic year and once in the spring term, the researchers ranked students by how many friends they had and their social influence – with the latter determined by how well connected their friends were. The researchers also asked each participant if they knew whether given pairs of students were friends. The results reveal the number of friendships people reported changed little over time, however the friendships between individuals, and people's level of influence, shifted. 'Popularity does not really change over the course of the year,' said Dr Oriel FeldmanHall, co-author of the study from Brown University. 'What changes dramatically is the people who were the most influential early on were no longer the most influential by the end of the year.' This shifting network, the researchers add, became more stable as the academic year went on. FeldmanHall said it is not clear what made people influential early in the study, however the students who rose to become the most influential by the end were those who had early insights about how all their peers were connected. 'To become influential, you need to know who is friends with whom, and you need to have a bird's eye view of how people cluster into different social groups or cliques,' said Aslarus, adding individuals can use that knowledge to become more influential – for example by making new friendships or being an effective matchmaker. Aslarus added that it is only after becoming influential that people develop more detailed knowledge about individual friendships. 'Knowing about your network predicts becoming influential over time, more so than just having lots of friends,' she said. 'So, social knowledge seems to be a key first step toward becoming better-connected in your network.'
Sky News
3 days ago
- Sky News
'Pioneering' new scanner used for brain tumour patients trialled in world-first
A "pioneering" new scanner derived from MRI technology could be used to track brain cancer spread and lead to improved treatment for patients, scientists have said. Researchers at the University of Aberdeen and NHS Grampian have been awarded £350,000 funding by the Scottish government to generate never-before-seen images of glioblastoma brain tumours. It is hoped the technology will improve treatment and quality of life for patients by investigating a new way to scan the tumours. Glioblastoma is the most common and aggressive type of brain tumour with more than 3,000 new patients in the UK diagnosed each year. The University of Aberdeen said half of all patients die within 15 months of diagnosis even after extensive surgery, radiotherapy and chemotherapy. Field cycling imaging (FCI) is a new and specialist type of low-field MRI scan pioneered in Aberdeen and has already been found to be effective in detecting tumours in breast tissue and brain damage in stroke patients. It is hoped it can now be used to help brain tumour patients. Full body MRI scanners were invented at the Scottish university 50 years ago, but the FCI scanner is the only one of its type used on patients anywhere in the world. The FCI derives from MRI but can work at low and ultra-low magnetic fields, which means it is capable of seeing how organs are affected by diseases in ways that were previously not possible. It can also vary the strength of the magnetic field during the patient's scan - acting like multiple scanners and extracting more information about the tissues. The tech can detect tumours without having to inject dye into the body, which can be associated with kidney damage and allergic reactions in some patients. Those involved in the project will scan glioblastoma patients undergoing chemotherapy after surgery and chemoradiotherapy. It is hoped the research will establish that, unlike conventional MRI scans, FCI can tell the difference between tumour growth and progression, and "pseudo-progression" which looks like tumour but is not cancerous tissue, which could improve care and quality of life. The new tech was described as "another example of the pioneering work coming out of the University of Aberdeen", by the charity Friends of ANCHOR. Professor Anne Kiltie, who is leading the study, said: "If we can detect true tumour progression early, we can swap the patient to a potentially more beneficial type of chemotherapy. "Also, being able to verify that a patient has pseudo-progression will prevent effective chemotherapy being stopped too early, because it was thought that the tumour has progressed, thus worsening prognosis. "Providing certainty will also reduce anxiety for both patients and relatives and improve the quality of life of patients. "Importantly, having a reliable method to identify progressive disease will allow development and more precise evaluation of emerging potential treatments. This is of particular importance as patients currently have a limited choice of treatments for combating their cancer. Scotland and beyond."
BBC News
3 days ago
- BBC News
Aberdeen scanner study could improve brain tumour treatments
Scientists at the University of Aberdeen and NHS Grampian have secured funding to generate never-before-seen brain tumour images with the aim of improving of all glioblastoma patients die within 15 months of diagnosis even after surgery, radio and scans used to monitor a tumour's behaviour can be imprecise but it is hoped the Field Cycling Imaging (FCI) scanner - developed in Aberdeen - will give clinicians better £350,000 in support - from the Scottish government - will fund a trial which will be carried out on a group of 18 patients. MRI scanners were invented at the University of Aberdeen 50 years ago, but the new FCI scanner is the only one of its type used on patients anywhere in the can work at low and ultra-low magnetic fields which means it is capable of seeing how organs are affected by diseases in ways that were not previously can vary the strength of the magnetic field during the patient's scan - acting like multiple scanners and extracting more information about the new technology can detect tumours without having to inject dye into the body, which can be associated with kidney damage and allergic reactions in some team of doctors and scientists involved will scan glioblastoma patients undergoing chemotherapy after surgery and chemoradiotherapy. It is hoped the research will establish that, unlike conventional MRI scans, FCI can tell the difference between tumour growth and progression, and "pseudo-progression" which looks like a tumour but is not cancerous Anne Kiltie, chair in clinical oncology at the University of Aberdeen, who is leading the study, said: "We already have evidence that FCI is effective in detecting tumours in breast tissue and brain damage in stroke patients."Applying this exciting new technology to glioblastoma patients could give us a much more accurate and detailed picture of what is going on in their brain."If we can detect true tumour progression early, we can swap the patient to a potentially more beneficial type of chemotherapy."Providing certainty will also reduce anxiety for both patients and relatives and improve the quality of life of patients."Prof Kiltie's role at the university is fully funded by the charity Friends of ANCHOR through its Dream Big executive Sarah-Jane Hogg welcomed the "really promising" development and thanked donors and fundraisers for their support.
